BeOne Medicines AG (ONC)

NASDAQ: ONC · Real-Time Price · USD

346.50

-7.33 (-2.07%)

At close: Sep 15, 2026, 4:00 PM EDT

340.95

-5.55 (-1.60%)

Pre-market: Sep 16, 2026, 4:06 AM EDT

BeOne Medicines AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	39,398	33,619	19,667	18,862	22,843	27,843
Market Cap Growth	10.43%	70.94%	4.27%	-17.43%	-17.96%	18.51%
Enterprise Value	36,349	31,487	18,005	16,441	18,473	24,626
Last Close Price	346.50	303.81	184.71	180.36	219.94	270.93

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	61.99	117.17	-	-	-	-
Forward PE	43.37	66.95	76.37	76.37	76.37	76.37
PS Ratio	6.43	6.29	5.16	7.67	16.13	23.67
PB Ratio	7.57	7.71	5.90	5.33	5.21	4.54
P/TBV Ratio	7.71	7.82	5.99	5.42	5.26	4.58
P/FCF Ratio	29.62	35.70	-	-	-	-
P/OCF Ratio	26.55	29.82	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	5.93	5.89	4.72	6.69	13.05	20.94
EV/EBITDA Ratio	33.92	54.40	-	-	-	-
EV/EBIT Ratio	39.38	70.42	-	-	-	-
EV/FCF Ratio	27.33	33.44	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.40	0.46	0.32	0.26	0.14	0.11
Debt / EBITDA Ratio	1.86	3.28	-	-	-	-
Debt / FCF Ratio	1.54	2.12	-	-	-	-
Net Debt / Equity Ratio	-0.59	-0.58	-0.46	-0.63	-0.90	-0.97
Net Debt / EBITDA Ratio	-2.84	-4.40	3.86	2.00	2.28	4.25
Net Debt / FCF Ratio	-2.29	-2.70	2.44	1.30	2.16	3.80
Asset Turnover	0.79	0.76	0.65	0.40	0.19	0.17
Inventory Turnover	1.10	1.21	1.30	1.09	1.09	0.99
Quick Ratio	2.91	2.97	1.51	1.97	3.22	4.45
Current Ratio	3.41	3.41	1.80	2.32	3.55	4.76
Return on Equity (ROE)	14.66%	7.46%	-18.77%	-22.26%	-38.11%	-29.15%
Return on Assets (ROA)	7.46%	3.96%	-6.06%	-12.39%	-15.00%	-12.72%
Return on Invested Capital (ROIC)	33.62%	17.11%	-36.89%	-138.75%	-549.14%	-
Return on Capital Employed (ROCE)	13.10%	7.00%	-15.30%	-30.20%	-36.40%	-20.70%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	1.66%	0.85%	-3.28%	-4.67%	-8.77%	-5.24%
FCF Yield	3.38%	2.80%	-3.22%	-9.12%	-7.98%	-5.61%
Buyback Yield / Dilution	-8.01%	-7.75%	-0.86%	-1.22%	-11.15%	-11.16%

SEC Filings: 10-K · 10-Q